
Cancer therapy has progressed remarkably in recent zzso In no area has this been more apparent than in the development of zzso zzso particularly those using drugs that inhibit the activity of certain zzso zzso zzso zzso or zzso of which are zzso or strongly zzso to zzso However, some of these therapies have been associated with toxicity to the zzso Here we zzso what is known about the zzso of cancer drugs that target zzso zzso We focus on basic mechanisms through which interruption of specific zzso pathways leads to zzso dysfunction and/or death, and contrast this with therapeutic responses in cancer zzso 

